As rates of obesity have increased over the last 20 years, demand for medicines to treat obesity has soared, resulting in shortages of critical ingredients needed to manufacture these drugs. These treatments – called GLP-1s – help manage type 2 diabetes and effectively promote weight loss. Fortunately, the Food and Drug Administration (FDA) recently announced […]
Author Archives: Philip J. Schneider
Philip J. Schneider, MS FASHP FFIP is a Professor at Ohio State University College of Pharmacy and Past President of the American Society of Health-system Pharmacists (ASHP). He wrote this for InsideSources.com.